Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer's disease.
Alzforum,
Xie L, Das SR, Wisse LE, Ittyerah R, de Flores R, Shaw LM, Yushkevich PA, Wolk DA, Alzheimer’s Disease Neuroimaging Initiative.